This course aims to improve learner competence and performance for scientists to more accurately design clinical trials and for radiologists to more accurately interpret clinical trials based imaging studies.
Imaging Biomarkers in Clinical Trials: Current Practice & Future Trends
Date: 04/27/2012 - 04/28/2012Description:
Imaging biomarkers serve as important endpoints for clinical trials in the approval process for therapeutic drugs. Various criteria have been developed for objective interpretation of imaging studies. Additionally, there are emerging imaging techniques that have the potential for applications as surrogate endpoints for clinical trials. In this program, taking place April 27 and 28, 2012, at Mass General, we will review the current practice of imaging biomarkers in clinical trials in oncology, cardiovascular, metabolic, bone and joint diseases. Additionally, we will highlight advanced imaging techniques that have potential as surrogate biomarkers.
Agenda:
Please click here for agendA >
(Presentations will be posted on the above page when the event takes place.)
Location
O'Keeffe Auditorium, Massachusetts General Hospital
Contact
Fabiola L. Khan
CME Program Coordinator
REMS Media Services
2 Emerson Place
Boston, MA 02114
Phone: 617-726-2970
Fax: 617-726-7508
flkhan@partners.org
Your gift of any amount will open new doors in outstanding patient care, research, clinical education and community outreach at Mass General.
Driving to Mass General? Get driving directions or locate a parking lot on the hospital's main campus.